EA201990261A1 - 2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS - Google Patents

2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS

Info

Publication number
EA201990261A1
EA201990261A1 EA201990261A EA201990261A EA201990261A1 EA 201990261 A1 EA201990261 A1 EA 201990261A1 EA 201990261 A EA201990261 A EA 201990261A EA 201990261 A EA201990261 A EA 201990261A EA 201990261 A1 EA201990261 A1 EA 201990261A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrasines
substituted
methyl
dub
triple
Prior art date
Application number
EA201990261A
Other languages
Russian (ru)
Inventor
Ашутош Джогалекар
Уолтер ВОН
Елена С. Колтун
Адриан Джилл
Кевин Меллем
Наинг Аай
Андреас Бакл
Кристофер Семко
Герт Кисс
Original Assignee
Революшн Медсинз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Революшн Медсинз, Инк. filed Critical Революшн Медсинз, Инк.
Priority claimed from PCT/US2017/041577 external-priority patent/WO2018013597A1/en
Publication of EA201990261A1 publication Critical patent/EA201990261A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение направлено на ингибиторы SHP2 и их применение в лечении заболевания. Также раскрыты фармацевтические композиции, содержащие таковые.The present invention is directed to SHP2 inhibitors and their use in the treatment of disease. Also disclosed are pharmaceutical compositions containing them.

EA201990261A 2017-01-23 2017-07-11 2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS EA201990261A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762449523P 2017-01-23 2017-01-23
PCT/US2017/041577 WO2018013597A1 (en) 2016-07-12 2017-07-11 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors

Publications (1)

Publication Number Publication Date
EA201990261A1 true EA201990261A1 (en) 2019-06-28

Family

ID=66998651

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990261A EA201990261A1 (en) 2017-01-23 2017-07-11 2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS

Country Status (1)

Country Link
EA (1) EA201990261A1 (en)

Similar Documents

Publication Publication Date Title
PH12020550857A1 (en) Polycyclic compounds as allosteric shp2 inhibitors
MX2023004037A (en) Bicyclic compounds as allosteric shp2 inhibitors.
MX2019008696A (en) Pyridine compounds as allosteric shp2 inhibitors.
PH12020550216A1 (en) Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
MX2022007607A (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors.
EA202092896A1 (en) HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
EA201891083A1 (en) COMPOSITIONS OF ANTIBODIES TO CD38 FOR SCRAPTURE AND THEIR APPLICATION
EA202091709A1 (en) DNA PC INHIBITORS
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201991183A1 (en) NEW GLUTAMINASE INHIBITORS
EA201792028A1 (en) ALPHA-CYNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
EA201891526A3 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
EA202091708A1 (en) DNA PC INHIBITORS
EA201992137A1 (en) Pyrimidopyrimidinones as Wee-1 Kinase Inhibitors
EA201792341A1 (en) DERIVATIVES OF PYRAZOLA SUITABLE AS INHIBITOR PROTEINS ACTIVATING 5-LIPOXYGENASE (FLAP)
EA202191122A1 (en) SELECTIVE TO RGMc INHIBITORS AND THEIR APPLICATION
EA202191114A1 (en) PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION
MX2020005841A (en) 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors.
EA202190057A1 (en) SOLUBILIZED APIRAZES, METHODS AND APPLICATION
PH12019501999A1 (en) Pyrazole derivatives as bromodomain inhibitors
EA202191446A1 (en) COMPOSITIONS FOR IMPROVING SEXUAL FUNCTIONS
EA202092446A1 (en) THIAZOL- OR THIADIAZOL-SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS Vps34 INHIBITORS
EA201990261A1 (en) 2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS